Plasma Therapy Market by Type, Application

List of Tables

The Plasma Therapy Market is projected to reach USD 781.95 million by 2030 from USD 328.91 million in 2022, at a CAGR of 11.43% during the forecast period.

Global Plasma Therapy Market

KEY MARKET STATISTICS
Base Year Value [2022]	USD 328.91 million
Estimated Year Value [2023]	USD 359.73 million
Forecast Year Value [2030]	USD 781.95 million
CAGR (%)	11.43%

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Plasma Therapy Market.

Based on Type, market is studied across Leucocyte-rich PRP, Leukocyte-rich Fibrin (L-PRF), Pure Platelet-rich Fibrin (PRF), and Pure PRP. The Pure PRP is projected to witness significant market share during forecast period.

Based on Application, market is studied across Dental, Dermatology, Nerve Injury, and Orthopedics. The Orthopedics is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Plasma Therapy Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Plasma Therapy Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Plasma Therapy Market, highlighting leading vendors and their innovative profiles. These include Abeona Therapeutics Inc., ADMA Biologics, Inc., Arthrex, Inc., Bio Products Laboratory Ltd., Biotest AG, China Biologic Products, Inc., CSL Limited, Emergent BioSolutions Inc., Exactech Inc., GC Pharma, Global Stem Cells Group, Inc., Green Cross Corporation, Grifols, S.A., Hualan Biological Engineering Inc., Interstate Blood Bank, Inc., Japan Blood Products Organization, Johnson & Johnson Services, Inc., Kedrion S.p.A., LFB S.A., Octapharma AG, Regen Lab SA, Shanghai RAAS Blood Products Co., Ltd., Stryker Corporation, Takeda Pharmaceutical Company Limited, Terumo Corporation, and Zimmer Biomet Holdings, Inc.

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Plasma Therapy Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Plasma Therapy Market?

3. What is the competitive strategic window for identifying opportunities in the Plasma Therapy Market?

4. What are the latest technology trends and regulatory frameworks in the Plasma Therapy Market?

5. What is the market share of the leading vendors in the Plasma Therapy Market?

6. Which modes and strategic moves are suitable for entering the Plasma Therapy Market?

Product Code: MRR-DD0700E81EB3

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Plasma Therapy Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Prevalence of infectious and chronic diseases worldwide
  - 5.1.1.2. Inclination towards early diagnosis and treatment of diseases
  - 5.1.1.3. Increase in number of clinical trials to test efficacy of plasma therapy
- 5.1.2. Restraints
  - 5.1.2.1. High cost of plasma therapy treatment
- 5.1.3. Opportunities
  - 5.1.3.1. Advancements in platelet-rich plasma therapy
  - 5.1.3.2. Emerging use of plasma therapy in dermatology
- 5.1.4. Challenges
  - 5.1.4.1. Adverse effects associated with the plasma therapy
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Plasma Therapy Market, by Type

6.1. Introduction
6.2. Leucocyte-rich PRP
6.3. Leukocyte-rich Fibrin (L-PRF)
6.4. Pure Platelet-rich Fibrin (PRF)
6.5. Pure PRP

7. Plasma Therapy Market, by Application

7.1. Introduction
7.2. Dental
7.3. Dermatology
7.4. Nerve Injury
7.5. Orthopedics

8. Americas Plasma Therapy Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Plasma Therapy Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Plasma Therapy Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

12.1. Key Company Profiles
- 12.1.1. Abeona Therapeutics Inc.
- 12.1.2. ADMA Biologics, Inc.
- 12.1.3. Arthrex, Inc.
- 12.1.4. Bio Products Laboratory Ltd.
- 12.1.5. Biotest AG
- 12.1.6. China Biologic Products, Inc.
- 12.1.7. CSL Limited
- 12.1.8. Emergent BioSolutions Inc.
- 12.1.9. Exactech Inc.
- 12.1.10. GC Pharma
- 12.1.11. Global Stem Cells Group, Inc.
- 12.1.12. Green Cross Corporation
- 12.1.13. Grifols, S.A.
- 12.1.14. Hualan Biological Engineering Inc.
- 12.1.15. Interstate Blood Bank, Inc.
- 12.1.16. Japan Blood Products Organization
- 12.1.17. Johnson & Johnson Services, Inc.
- 12.1.18. Kedrion S.p.A.
- 12.1.19. LFB S.A.
- 12.1.20. Octapharma AG
- 12.1.21. Regen Lab SA
- 12.1.22. Shanghai RAAS Blood Products Co., Ltd.
- 12.1.23. Stryker Corporation
- 12.1.24. Takeda Pharmaceutical Company Limited
- 12.1.25. Terumo Corporation
- 12.1.26. Zimmer Biomet Holdings, Inc
12.2. Key Product Portfolio

13. Appendix

13.1. Discussion Guide
13.2. License & Pricing